Using the Immune System to Treat Cancer
Ronald Levy - Robert K. and Helen K. Summy Professor in the School of Medicine and Professor of Medicine (Oncology)
Bio-X Affiliated Faculty
Dr. Levy's research concentrates on the study of malignant lymphoma and tumors of the immune system using the tools of immunology and molecular biology to develop a better understanding of the initiation and progression of the malignant process.
Stanford Bio-X Seed Grants
Interdisciplinary Initiatives Program Seed Grant: Multiparametric imaging of immune checkpoint inhibitor therapy
Interdisciplinary Initiatives Program Round 11 - 2022
Rapid Synthesis of Vaccines for Treating B-Cell Lymphoma
Interdisciplinary Initiatives Program Round 1 - 2000
Research News
PET scan tracer predicts success of cancer ‘vaccine’
May 14, 2018 - Stanford Medicine News Center
With a radioactive tracer, scientists can use a PET scan to quickly tell whether a cancer...
Previously elusive targets for cancer immunotherapy identified
March 30, 2017 - Stanford Medicine Scope
A collaborative team including Bio-X affiliates Ash Alizadeh, Joshua Elias, Ron Levy, Mark Davis, and Jan...
DNA sequencing determines lymphoma origin, prognosis
November 9, 2016 - Stanford Medicine News Center
A study, under Bio-X affiliates Maximilian Diehn, Ash Alizadeh, and Ron Levy of 92 lymphoma...